BioMed Research International

Research Article

Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma

Table 1

Association of pretreatment NLR, LMR, and PLR with clinicopathologic characteristics in patients with nasopharyngeal carcinoma.


Characteristics	Case	NLR			LMR			PLR
Characteristics	Case	<2.28	≥2.28	P	<2.26	≥2.26	P	<174	≥174	P

Age (year)
<45	55	28	27	0.561	10	45	0.924	41	14	0.833
≥45	85	39	46	0.561	16	69	0.924	62	23	0.833
Sex
Male	101	47	54	0.614	21	80	0.277	76	25	0.469
Female	39	20	19	0.614	5	34	0.277	27	12	0.469
Pathology (WHO)
Type I/II	23	11	12	0.997	5	18	0.669	16	7	0.634
Type III	117	56	61	0.997	21	96	0.669	87	30	0.634
T classification
T₁-T₂	63	36	27	0.047	8	55	0.106	49	14	0.307
T₃-T₄	77	31	46	0.047	18	59	0.106	54	23	0.307
N classification
N₀-N₁	43	26	17	0.047	8	35	0.995	33	10	0.571
N₂-N₃	97	41	56	0.047	18	79	0.995	70	27	0.571
Overall stage
I-II	19	14	5	0.015	2	17	0.332	15	4	0.568
III-IVa	121	53	68	0.015	24	97	0.332	88	33	0.568

NLR: neutrophil to lymphocyte ratio; LMR: lymphocyte to monocyte ratio; PLR: platelet to lymphocyte ratio; Type I: keratinizing squamous cell carcinoma; Type II: differentiated nonkeratinizing carcinoma; Type III: undifferentiated nonkeratinizing carcinoma.